Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 208 is a member of the Kruppel-type zinc finger transcription factors containing C2H2 motifs, encoded by the ZNF208 gene on chromosome 19. It binds specific DNA sequences to regulate gene transcription, influencing various cell processes, especially transcriptional control mechanisms essential for cellular function and development. Several genetic variants in ZNF208 are associated with increased risk for certain cancers (including esophageal and laryngeal cancers), vascular diseases (such as ischemic stroke and coronary heart disease), and may relate to telomere length, with implications for aging and chronic disease. Despite these associations, ZNF208 itself is not considered a druggable or direct therapeutic target at present.
Not established for pharmacologic targeting; ZNF208 functions principally as a transcription factor that recognizes specific DNA sequences and regulates gene expression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 208 (ZNF208).